Sort
64,565 grants matching “drug discovery”
Shared Resource Management
$2,736,938Richard D Schulick · University Of Colorado Denver · P30 · FY2022 · CA
Targeting Transcription and Splicing in Cancer
$2,735,999Christopher Vakoc · Cold Spring Harbor Laboratory · P01 · FY2024 · CA
Discovery of genetic interactions in cancer
$2,732,082Eytan Ruppin · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Asthma Inflammation Research
$2,731,369Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru · P01 · FY2019 · HL
Asthma Inflammation Research
$2,731,369Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru · P01 · FY2018 · HL
Asthma Inflammation Research
$2,731,369Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru · P01 · FY2020 · HL
Development of Protease Inhibitor to Treat Smallpox
$2,730,597Transtech Pharma, Inc. · UC1 · FY2004 · AI
Medicinal Chemistry and Lead Development Core
$2,729,679Joseph A Maddry · University Of Alabama At Birmingham · U19 · FY2017 · AI
Enhancement of Cancer Research at Clark Atlanta University
$2,726,079Daqing Wu · Clark Atlanta University · U54 · FY2023 · MD
Helping to End Addiction Long-term (HEAL): Induced Pluripotent Stem Cell (iPSC)-Derived Cell Types for Pain, Addiction and Overdose
$2,726,004Ilyas Singec · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Pharmacogenomics of Bronchodilator Response in Minority Children with Asthma
$2,725,587Esteban Gonzalez Burchard · University Of California, San Francisco · R01 · FY2014 · HL
Discovery and validation of novel targets for pharmacotherapy of alcoholism
$2,725,388Markus Heilig · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2011 · AA
Genetic Analysis of Resistance to Viral Infection
$2,725,363Bruce A Beutler · Ut Southwestern Medical Center · P01 · FY2012 · AI
Framingham Project/Levy
$2,722,934Daniel Levy · National Heart, Lung, And Blood Institute · ZIA · FY2009 · HL
REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY EVALUATION AND DEVELOPMENT
$2,721,179Mark Lee · Fisher Bioservices, Inc. · N02 · FY2021 · CA
Discovery of genetic interactions in cancer
$2,720,657Eytan Ruppin · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Consolidated Basic Cancer Research Program
$2,719,954Dario C. Altieri · Wistar Institute · P30 · FY2020 · CA
Consolidated Basic Cancer Research Program
$2,714,982Dario C. Altieri · Wistar Institute · P30 · FY2021 · CA
Consolidated Basic Cancer Research Program
$2,714,982Dario C. Altieri · Wistar Institute · P30 · FY2023 · CA
Consolidated Basic Cancer Research Program
$2,714,982Dario C. Altieri · Wistar Institute · P30 · FY2022 · CA
Therapeutic Targeting of Vascular Subphenotypes of Lung Disease
$2,714,385Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · P01 · FY2018 · HL
Genetic and clinical studies of Gaucher disease and other lysosomal disorders
$2,714,052Ellen Sidransky · National Human Genome Research Institute · ZIA · FY2023 · HG
Therapeutic Targeting of Vascular Subphenotypes of Lung Disease
$2,713,336Alison Morris · University Of Pittsburgh At Pittsburgh · P01 · FY2020 · HL
Targeting Vessels in Tumors
$2,713,198Mark A Talamini · University Of California, San Diego · P01 · FY2009 · CA
Therapeutic Targeting of Vascular Subphenotypes of Lung Disease
$2,713,014Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · P01 · FY2019 · HL